Litigation Details for Baxter Healthcare Corporation v. Hospira, Inc. (D. Del. 2018)
✉ Email this page to a colleague
Baxter Healthcare Corporation v. Hospira, Inc. (D. Del. 2018)
| Docket | ⤷ Sign Up | Date Filed | 2018-02-22 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 35:0145 | Assigned To | Richard Gibson Andrews |
| Jury Demand | Plaintiff | Referred To | |
| Patents | 6,716,867; 8,242,158; 8,338,470; 8,455,527 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Baxter Healthcare Corporation v. Hospira, Inc.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Baxter Healthcare Corporation v. Hospira, Inc. (D. Del. 2018)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2018-02-22 | 3 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 6,716,867 B1; US 8,242,158 …22 February 2018 1:18-cv-00303-RGA Patent Plaintiff District Court, D. | External link to document | |
| 2018-10-29 | 61 | construction of terms in U.S. Patent No. 6,716,867 ("the '867 patent"). I have considered …providing claim construction for terms in U.S. Patent No. 6,716,867. Signed by Judge Richard G. Andrews on 10…quot;It is a bedrock principle of patent law that the claims of a patent define the invention to which … construing patent claims, a court considers the literal language of the claim, the patent specification…citation omitted). II. PATENT AT ISSUE Claim 1 of the '867 patent reads (as amended by the | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
